BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28436028)

  • 1. Chronic bullous disease of childhood with IgG reactivity to p200 antigen.
    Patsatsi A; Meltzanidou P; Katafigiotis S; Sotiriadis D; Schmidt E; Lambropoulos A
    Int J Dermatol; 2017 Jul; 56(7):773-775. PubMed ID: 28436028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-p200 pemphigoid: a spectacular response to dapsone].
    Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
    Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
    Raffin D; Delaplace M; Roussel A; Estève E
    Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-p200 pemphigoid: diagnosis and treatment of a case presenting as an inflammatory subepidermal blistering disease.
    Egan CA; Yee C; Zillikens D; Yancey KB
    J Am Acad Dermatol; 2002 May; 46(5):786-9. PubMed ID: 12004326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].
    Drerup KA; Wehkamp U
    Hautarzt; 2020 Feb; 71(2):130-133. PubMed ID: 31501972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
    Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
    J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
    Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
    J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
    [No Abstract]   [Full Text] [Related]  

  • 8. Subepidermal blistering disease with 3 distinct autoantibodies: anti-BP230, anti-laminin gamma-1, and anti-laminin-332.
    Kikuchi K; Natsuga K; Shinkuma S; Nishie W; Kajita S; Sato H; Shimizu H
    J Am Acad Dermatol; 2011 Oct; 65(4):878-880. PubMed ID: 21920249
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone.
    Yamane N; Sawamura D; Nishie W; Abe M; Kodama K; Adachi K; Nakamura H; Ishii N; Hashimoto T; Shimizu H
    Br J Dermatol; 2007 May; 156(5):1075-8. PubMed ID: 17381449
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenicity of autoantibodies in anti-p200 pemphigoid.
    Vafia K; Groth S; Beckmann T; Hirose M; Dworschak J; Recke A; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
    PLoS One; 2012; 7(7):e41769. PubMed ID: 22911854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid with IgG autoantibodies to BP180 C-terminal domain and desmocollin 3 associated with transverse colon cancer.
    Yamashita H; Ansai S; Ueno T; Osada S; Kawana S; Koga H; Ishii N; Hashimoto T
    Eur J Dermatol; 2015; 25(5):515-6. PubMed ID: 26693637
    [No Abstract]   [Full Text] [Related]  

  • 12. Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332.
    Jedlickova H; Niedermeier A; Zgažarová S; Hertl M
    Dermatology; 2011; 222(3):193-5. PubMed ID: 21228551
    [No Abstract]   [Full Text] [Related]  

  • 13. Pemphigoid without mucosal involvement showing autoantibodies against laminin-332 γ2 subunit.
    Endo Y; Kato M; Kitoh A; Kore-Eda S; Fukuda S; Hashimoto T; Toda K; Miyachi Y; Utani A
    Br J Dermatol; 2010 Nov; 163(5):1120-2. PubMed ID: 20586779
    [No Abstract]   [Full Text] [Related]  

  • 14. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
    Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
    Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
    JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
    Yasuda H; Tomita Y; Shibaki A; Hashimoto T
    Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological investigation of bullous scabies and review of the published work.
    Kokubu H; Takahashi T; Tateishi C; Tsuruta D; Hashimoto T; Tanaka T; Fujimoto N
    J Dermatol; 2019 Sep; 46(9):e324-e325. PubMed ID: 30969443
    [No Abstract]   [Full Text] [Related]  

  • 19. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
    Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone for the treatment of bullous pemphigoid.
    Piamphongsant T
    Asian Pac J Allergy Immunol; 1983 Jun; 1(1):19-21. PubMed ID: 6398078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.